Allogeneic Hematopoietic Cell Transplantation
Showing 1 - 25 of >10,000
Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- Hematologic Malignancy
- CliniMACS®
- (no location specified)
Oct 17, 2023
Allogeneic Hematopoietic Cell Transplantation Trial in Cleveland (Nicotinamide riboside (NR))
Recruiting
- Allogeneic Hematopoietic Cell Transplantation
- Nicotinamide riboside (NR)
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Jan 17, 2023
Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Seattle (Fecal Microbiota Transplantation Capsule, Placebo)
Not yet recruiting
- Acute Graft Versus Host Disease
- Hematopoietic and Lymphoid System Neoplasm
- Fecal Microbiota Transplantation Capsule
- Placebo
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 6, 2023
Allogeneic Hematopoietic Cell Transplantation Trial (Alemtuzumab)
Not yet recruiting
- Allogeneic Hematopoietic Cell Transplantation
- (no location specified)
Aug 12, 2022
Transplant Complication Trial (Pooled allogeneic fecal microbiotherapy, Placebo)
Not yet recruiting
- Transplant Complication
- Pooled allogeneic fecal microbiotherapy
- Placebo
- (no location specified)
Feb 27, 2023
Acute Lymphoblastic Leukemia Trial in Houston (Blinatumomab, Hematopoietic Cell Transplantation)
Completed
- Acute Lymphoblastic Leukemia
- Blinatumomab
- Hematopoietic Cell Transplantation
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 30, 2022
Cytomegaloviral Infection, Hematopoietic and Lymphoid System Tumor Trial in Buffalo (Allogeneic Hematopoietic Stem Cell
Not yet recruiting
- Cytomegaloviral Infection
- Hematopoietic and Lymphoid System Neoplasm
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 16, 2022
BK Virus Disease After Allogeneic Hematopoietic-cell
Active, not recruiting
- BK Virus Infection
- Symptom index questionnaire
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 27, 2023
Hematologic Malignancy Trial in Duarte (B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010))
Recruiting
- Hematologic Malignancy
- B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010)
-
Duarte, CaliforniaCity of Hope
Oct 20, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, drug, biological, other)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 10, 2023
Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,
Recruiting
- Lymphoproliferative Disorders
- +4 more
- Immunosuppression Only Conditioning
- +3 more
-
Bethesda, Maryland
- +1 more
Jan 25, 2023
Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)
Suspended
- Hematologic Neoplasms
- donor lymphocyte infusion
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 30, 2022
Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)
Not yet recruiting
- Myelofibrosis
- Pegylated interferon alpha2a
-
Salt Lake City, UtahHuntsman Cancer Institute at the University of Utah
Sep 6, 2022
Myeloablative Allogeneic Hematopoietic Cell Transplantation, Intraoral Photobiomodulation Therapy, Oral Mucositis Trial in
Recruiting
- Myeloablative Allogeneic Hematopoietic Cell Transplantation
- +3 more
- THOR LX2.3 with LED Lollipop
-
Boston, MassachusettsBrigham and Women's Hospital
Jun 27, 2022
MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)
Active, not recruiting
- Myelodysplastic Syndromes
- cyclophosphamide, fludarabine, and antithymocyte globulin
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023
Cytomegalovirus Infections Trial (Cytotect®CP)
Recruiting
- Cytomegalovirus Infections
-
Lille, FranceHop Claude Huriez Chu Lille
Nov 8, 2022
Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,
Recruiting
- Myelodysplastic Syndrome
- +4 more
- Rituximab
- +6 more
-
Bethesda, Maryland
- +1 more
Aug 20, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in
Not yet recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
- Fludarabine
- +2 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023
cGVHD Trial in Guanzhou (Belimumab (Benlysta))
Withdrawn
- cGVHD
- Belimumab (Benlysta)
-
Guanzhou, ChinaDepartment of Hematology, Nanfang Hospital, Southern Medical Uni
Jan 16, 2023
Blood Cancer, Refractory Immune Cytopenias Trial in United States (Isatuximab)
Not yet recruiting
- Blood Cancer
- Refractory Immune Cytopenias
- Isatuximab
-
Basking Ridge, New Jersey
- +6 more
May 15, 2023
Allogeneic Hematopoietic Cell Transplantation (HCT) Trial in Boston (FMT, Placebo)
Terminated
- Allogeneic Hematopoietic Cell Transplantation (HCT)
- FMT
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Nov 3, 2021
Relapsed Acute Myeloid Leukemia Trial in Saint Louis (Flotetuzumab, Donor lymphocyte infusion)
Recruiting
- Relapsed Acute Myeloid Leukemia
- Flotetuzumab
- Donor lymphocyte infusion
-
Saint Louis, MissouriWashington University School of Medicine
Sep 7, 2022
Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis
Recruiting
- Myelofibrosis
- Hematopoietic Stem Cell Transplant
-
Minneapolis, MinnesotaCenter for International Blood and Marrow Transplant Research
Mar 17, 2022